Adoptive immunotherapy with donor lymphocyte infusions after allogeneic HPC transplantation

被引:24
作者
Baron, F [1 ]
Beguin, Y [1 ]
机构
[1] Univ Liege, Dept Med, Div Hematol, Liege, Belgium
关键词
D O I
10.1046/j.1537-2995.2000.40040468.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:468 / 476
页数:9
相关论文
共 90 条
[11]  
BENYUNES MC, 1995, BONE MARROW TRANSPL, V16, P283
[12]   Long-term follow-up of allogeneic bone marrow transplantation in patients with poor prognosis non-Hodgkin's lymphoma [J].
Bernard, M ;
Dauriac, C ;
Drénou, B ;
Leberre, C ;
Branger, B ;
Fauchet, R ;
Le Prisé, PY ;
Lamy, T .
BONE MARROW TRANSPLANTATION, 1999, 23 (04) :329-333
[13]   Specific human cellular immunity to bcr-abl oncogene-derived peptides [J].
Bocchia, M ;
Korontsvit, T ;
Xu, Q ;
Mackinnon, S ;
Yang, SY ;
Sette, A ;
Scheinberg, DA .
BLOOD, 1996, 87 (09) :3587-3592
[14]   HSV-TK gene transfer into donor lymphocytes for control of allogeneic graft-versus-leukemia [J].
Bonini, C ;
Ferrari, G ;
Verzeletti, S ;
Servida, P ;
Zappone, E ;
Ruggieri, L ;
Ponzoni, M ;
Rossini, S ;
Mavilio, F ;
Traversari, C ;
Bordignon, C .
SCIENCE, 1997, 276 (5319) :1719-1724
[15]   Donor lymphocyte infusion for a patient with relapsing myelodysplastic syndrome after allogeneic bone marrow transplantation [J].
Bressoud, A ;
Chapuis, B ;
Roux, E ;
Cabrol, C ;
Jeannet, M ;
Roosnek, E ;
Helg, C .
BLOOD, 1996, 88 (05) :1902-1903
[16]   T-CELL DEPLETION TO PREVENT GRAFT-VERSUS-HOST DISEASE AFTER BONE-MARROW TRANSPLANTATION [J].
CHAMPLIN, R .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1990, 4 (03) :687-698
[17]  
CHAMPLIN R, 1991, TRANSPLANT P, V23, P1695
[18]   Use of leukemic dendritic cells for the generation of antileukemic cellular cytotoxicity against Philadelphia chromosome-positive chronic myelogenous leukemia [J].
Choudhury, A ;
Gajewski, JL ;
Liang, JC ;
Popat, U ;
Claxton, DF ;
Kliche, KO ;
Andreeff, M ;
Champlin, RE .
BLOOD, 1997, 89 (04) :1133-1142
[19]   Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation [J].
Collins, RH ;
Shpilberg, O ;
Drobyski, WR ;
Porter, DL ;
Giralt, S ;
Champlin, R ;
Goodman, SA ;
Wolff, SN ;
Hu, W ;
Verfaillie, C ;
List, A ;
Dalton, W ;
Ognoskie, N ;
Chetrit, A ;
Antin, JH ;
Nemunaitis, J .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (02) :433-444
[20]  
Dazzi F, 1998, BLOOD, V92, p653A